NASDAQ:ICAD iCAD (ICAD) Stock Price, News & Analysis $1.86 +0.01 (+0.54%) (As of 10/31/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About iCAD Stock (NASDAQ:ICAD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get iCAD alerts:Sign Up Key Stats Today's Range$1.84▼$1.9050-Day Range$1.39▼$1.9652-Week Range$1.18▼$2.65Volume89,634 shsAverage Volume163,923 shsMarket Capitalization$49.36 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewiCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.Read More… Banking failure dead ahead (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. iCAD Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks8th Percentile Overall ScoreICAD MarketRank™: iCAD scored higher than 8% of companies evaluated by MarketBeat, and ranked 654th out of 670 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for iCAD.Read more about iCAD's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of iCAD is -16.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of iCAD is -16.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioiCAD has a P/B Ratio of 1.46. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about iCAD's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.94% of the float of iCAD has been sold short.Short Interest Ratio / Days to CoveriCAD has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in iCAD has recently increased by 8.72%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldiCAD does not currently pay a dividend.Dividend GrowthiCAD does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.94% of the float of iCAD has been sold short.Short Interest Ratio / Days to CoveriCAD has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in iCAD has recently increased by 8.72%, indicating that investor sentiment is decreasing significantly. News and Social Media2.4 / 5News Sentiment0.29 News SentimentiCAD has a news sentiment score of 0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 3 news articles for iCAD this week, compared to 2 articles on an average week.Search Interest1 people have searched for ICAD on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added iCAD to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, iCAD insiders have not sold or bought any company stock.Percentage Held by Insiders10.29% of the stock of iCAD is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 24.61% of the stock of iCAD is held by institutions.Read more about iCAD's insider trading history. Receive ICAD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iCAD and its competitors with MarketBeat's FREE daily newsletter. Email Address ICAD Stock News HeadlinesICAD, Inc. (ICAD): A Bull Case TheoryOctober 24, 2024 | msn.com3 US Penny Stocks With Market Caps At Least $40M To WatchOctober 23, 2024 | uk.finance.yahoo.comBanking failure dead aheadIf you missed it, my emergency election broadcast is now available - but will be removed soonOctober 31, 2024 | Porter & Company (Ad)Boeing tables 35% pay increaseOctober 21, 2024 | fxstreet.comIcade SA Expects Strong Financial Performance in 2024October 21, 2024 | markets.businessinsider.comICAD I, Abu Dhabi EmirateOctober 18, 2024 | msn.comiCAD (NASDAQ:ICAD) adds US$15m to market cap in the past 7 days, though investors from three years ago are still down 82%October 18, 2024 | finance.yahoo.comicad Inc (ICAD) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ShiftsOctober 10, 2024 | finance.yahoo.comSee More Headlines ICAD Stock Analysis - Frequently Asked Questions How have ICAD shares performed this year? iCAD's stock was trading at $1.77 on January 1st, 2024. Since then, ICAD stock has increased by 5.1% and is now trading at $1.86. View the best growth stocks for 2024 here. How were iCAD's earnings last quarter? iCAD, Inc. (NASDAQ:ICAD) posted its quarterly earnings results on Tuesday, August, 13th. The technology company reported ($0.07) earnings per share for the quarter. The technology company had revenue of $5.03 million for the quarter. iCAD had a negative net margin of 15.67% and a negative trailing twelve-month return on equity of 13.59%. Who are iCAD's major shareholders? Top institutional investors of iCAD include Greenwood Capital Associates LLC (1.11%) and Essex LLC (0.52%). Insiders that own company stock include Jonathan Go, Dana R Brown, Andy Sassine, Timothy Norris Irish, Michael S Klein, Charles Ross Carter and Susan Alyson Wood. View institutional ownership trends. How do I buy shares of iCAD? Shares of ICAD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of iCAD own? Based on aggregate information from My MarketBeat watchlists, some other companies that iCAD investors own include Enovix (ENVX), Globant (GLOB), Rambus (RMBS), Luminar Technologies (LAZR), Toast (TOST), COMPASS Pathways (CMPS) and Ginkgo Bioworks (DNA). Company Calendar Last Earnings8/13/2024Today10/31/2024Next Earnings (Estimated)11/11/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:ICAD CUSIPN/A CIK749660 Webwww.icadmed.com Phone(603) 882-5200Fax603-880-3843Employees67Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,850,000.00 Net Margins-15.67% Pretax Margin-24.03% Return on Equity-13.59% Return on Assets-10.43% Debt Debt-to-Equity RatioN/A Current Ratio4.24 Quick Ratio4.13 Sales & Book Value Annual Sales$18.80 million Price / Sales2.63 Cash FlowN/A Price / Cash FlowN/A Book Value$1.27 per share Price / Book1.46Miscellaneous Outstanding Shares26,540,000Free Float23,809,000Market Cap$49.36 million OptionableOptionable Beta1.50 Social Links 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report This page (NASDAQ:ICAD) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iCAD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iCAD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.